Parallel Trade for Pharma: Addressing Competition law and FMD challenges

Highly Anticipated Agenda Released for Europe's Only Parallel Trade Conference | 5 - 6 February 2019

SMi Group is proud to announce the return of Europe’s only Parallel Trade event conference, returning to Central London on 5^th & 6^th February 2019. The meeting will gather 90+ senior leaders in parallel trade to discuss upcoming trends and share best practices.

The 2019 event will hold a particular place of significance due to Brexit and the UK officially leaving the EU on the 29th of March 2019. As such, the UK will no longer be part of the EU free market; hence, having a significant impact on parallel trade.

Furthermore, the FMD (Falsified Medicines Directive) will be coming into effect in February 2019. This conference will give companies affected the perfect opportunity to discuss and consider the impact that the FMD implementation will have on their practices and on the market.

The 2019 Parallel Trade conference will cover the important issues of:

Patient safety
Brexit’s impact on parallel trade
The falsified medicines directive
The supply chain and shortages
The legal aspects of parallel trade within IP, anti-trust and competition law

This conference will enable you to update on parallel trade regulations to ensure compliance, recap on regional markets' parallel trade activities and outlooks and reassess and benchmark your supply chain and distribution model against peers for best practice.

2019 industry experts include:

Miranda Cole, Partner, Covington & Burling
Nerea Blanque, Senior Global Market Access & Pricing Manager, Almirall
Felipe Florez-Arango, CFO, Allergan
John Lisman, Attorney Consultant, Trainer, Lisman Legal Life Sciences B.V.
Shabnam Hanassab, Engagement Manager, IQVIA
Farasat A.S. Bokhari, Senior Lecturer, University of East Anglia
Flemming Wagner, CEO, Covington & Burling
Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceuticals Companies
Antonio Mendonca Alves, CEO, MD Pharma
Vimal Unewal, Senior Manager in Market Supply, Ferring Pharmaceuticals
Mike Isles, Executive Director, European Alliance for Access to Safe Medicines
Iona McCall, Senior Vice President, AlixPartners
Martin Slegl, Regional Principal of East Europe, IQVIA
Maarten Van Baelen, Market Access Director, Medicines for Europe
Christopher Stothers, Partner, Freshfields Bruckhaus Deringer

Parallel Trade 2019 will also be accompanied by two exclusive post- conference workshops, running on 4^th February 2019:

A: Parallel Trade & Brexit. What to expect?
Led by Key Pharmaceuticals Ltd

B: Understanding IP, regulatory & competition law issues in pharmaceuticals parallel trade

Led by Arnold & Porter LLP

For more information about the must-attend meeting please visit:
www.parallel-trade.com/Pr1pharmaph

For those interested in registering, there is currently a £200 early bird discount available for all registrations made before 30^th November 2018.

For media enquiries please contact Jinna Sidhu on +44 20 7827 6088 or email hsidhu@smi-online.co.uk

13^th Annual Parallel Trade

5^th – 6^th February 2019

Holiday Inn Kensington Forum, London, UK

#smiparalleltrade

---- ENDS ----

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at https://www.smgconferences.com/